2015

11/27/2015 Guerbet completes acquisition of Mallinckrodt’s Contrast Media and Delivery Systems business (CMDS)

Guerbet announces that it has completed its acquisition of the "contrast media and delivery systems" (CMDS) business of Mallinckrodt. The new entity brings together 2,500 employees, with a pro forma turnover of about €800M.

[more]


11/12/2015 Guerbet at RSNA 2015: Discover our diagnostic and interventional imaging solutions

RSNA 2015 | Booth #1924 – South Building – Hall A | 29 November to 4 December | McCormick Place | Chicago, United States

[more]


10/27/2015 Frost & Sullivan Applauds Guerbet's Syringe-free CT Contrast Injector, FlowSens®

On Thursday, October 22, Frost & Sullivan honoured recipients of "2015 Excellence in Best Practices Awards". FlowSens®, Guerbet innovative injection solution, received the "2015 European Contrast Auto-injector-CT Imaging Modality New Product Innovation Award"

[more]


10/27/2015 Fresh success for Guerbet at JFR 2015

Four days of meetings, 160 staff present, interventional radiology post-graduate training and a highly appreciated symposium on the topic of gadolinium deposits in the brain

[more]


10/22/2015 Revenue at 30 September 2015, up by 10.2% at constant exchange rates

Guerbet third-quarter revenue up by 14.6%. Cumulative revenue totalled €343.6 million, up by 10.2%.

[more]


10/05/2015 Guerbet at JFR 2015

JFR 2015 | Booth #101 | October 16-19 | Palais des Congrès Porte Maillot | Paris, France

[more]


09/29/2015 2015 half-year results: Growth in business activity on the four product segments

Current operating income: €30.1 M, an increase of more than 52%. Net financial debt down 36% to €53 M.

[more]


Displaying results 1 to 7 out of 27
<< First < Previous 1-7 8-14 15-21 22-27 Next > Last >>